Literature DB >> 9322943

Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation.

J A Vanderkuur1, E R Butch, S B Waters, J E Pessin, K L Guan, C Carter-Su.   

Abstract

We have shown previously that GH stimulates the mitogen-activated protein (MAP) kinases designated ERKs (extracellular signal-regulated kinases) 1 and 2. To examine pathways coupling GH receptor (GHR) to MAP kinase activation, we have determined the effects of GH on SHC-growth factor receptor bound 2-son of Sevenless (SHC-Grb2-SOS) association and activation of Ras, Raf, and MAP-ERK kinase (MEK). GH promoted the rapid, transient association of SHC with the Grb2-SOS complex, which correlated with the time course of Ras, Raf, and MEK activation. Despite the continuous presence of GH, these activation events were transient with Ras, Raf, and MEK returning to near basal activity by 15 or 30 min. The inactivation of Ras, Raf, and MEK directly correlated with the serine/threonine phosphorylation of SOS and dissociation of SOS from Grb2 but not Grb2 from tyrosine-phosphorylated SHC. Phosphorylation was blocked by the MEK inhibitor, PD98059. Based upon the established functions of the MAP kinase pathway, these data indicate that GH stimulation results in the assembly of a SHC-Grb2-SOS complex that serves to activate Ras and thereby engage the Raf-MEK-ERK pathway. Activation of this pathway generates a feedback kinase cascade that phosphorylates SOS resulting in the dissociation of SHC-Grb2 complexes from SOS, thereby causing a more rapid termination of the signaling pathway than would result from SHC dephosphorylation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9322943     DOI: 10.1210/endo.138.10.5453

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  23 in total

Review 1.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

Review 2.  Mechanotransduction in skeletal muscle.

Authors:  Thomas J Burkholder
Journal:  Front Biosci       Date:  2007-01-01

3.  Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes.

Authors:  S J MacKenzie; S J Yarwood; A H Peden; G B Bolger; R G Vernon; M D Houslay
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  Theoretical and experimental analysis links isoform-specific ERK signalling to cell fate decisions.

Authors:  Marcel Schilling; Thomas Maiwald; Stefan Hengl; Dominic Winter; Clemens Kreutz; Walter Kolch; Wolf D Lehmann; Jens Timmer; Ursula Klingmüller
Journal:  Mol Syst Biol       Date:  2009-12-22       Impact factor: 11.429

5.  Gamma interferon and lipopolysaccharide interact at the level of transcription to induce tumor necrosis factor alpha expression.

Authors:  J Y Lee; K E Sullivan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor.

Authors:  Anna M Mazurkiewicz-Munoz; Lawrence S Argetsinger; Jean-Louis K Kouadio; Allan Stensballe; Ole N Jensen; Joel M Cline; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 7.  Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling.

Authors:  Stuart J Frank
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-31       Impact factor: 2.673

8.  JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.

Authors:  Hui Jin; Nathan J Lanning; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2008-05-22

9.  Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.

Authors:  Shoshana Yakar; Jennifer Setser; Hong Zhao; Bethel Stannard; Martin Haluzik; Vaida Glatt; Mary L Bouxsein; John J Kopchick; Derek LeRoith
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

10.  Inherent sexually dimorphic expression of hepatic CYP2C12 correlated with repressed activation of growth hormone-regulated signal transduction in male rats.

Authors:  Chellappagounder Thangavel; Bernard H Shapiro
Journal:  Drug Metab Dispos       Date:  2008-06-16       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.